Medpace 

M$6,890
-M$765-9.99% Friday 15:19

Statistik

Harga Tertinggi Hari
6,890
Harga Terendah Hari
6,890
52M Tertinggi
7,655
52M Terendah
4,158
Volum
0
Volum Purata
0
Kapasiti Pasaran
133.17B
Nisbah P/E
33.63
Pendapatan Dividen
-
Dividen
-

Akan Datang

Pendapatan

21OctDijangka
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q3 2024
1.8
2.27
2.73
3.2
EPS yang dijangka
2.770639
EPS sebenar
3.01

Orang Lain Juga Mengikuti

Senarai ini berdasarkan senarai pantau orang di Stock Events yang mengikuti MEDP.MX. Ini bukan cadangan pelaburan.

Peserta

Senarai ini adalah analisis berdasarkan peristiwa pasaran terkini. Ini bukan cadangan pelaburan.

Mengenai

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
Show more...
CEO
Dr. August James Troendle M.D.
Pekerja
5000
Negara
United States
ISIN
US58506Q1094

Penyenaraian